Focus: CMP Pharma is a small-molecule generics and specialty pharmaceutical company founded in 1975, focused on nephrology, immunology, and infectious disease indications. The company operates as a niche player with a portfolio of established ANDA products.
Profile data last refreshed 15h ago · AI intelligence enriched 3w ago
CMP Pharma is a stable legacy generics operator best suited for candidates seeking operational roles in mature product commercialization, not career growth or innovation exposure.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Generic potassium-binding resin for nephrology; established market with high generic competition.
Help build intelligence for CMP Pharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from CMP Pharma's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Duplicate listing of same active ingredient; commodity market position.
Generic nasal corticosteroid; well-established indication with consistent demand in allergy/immunology.
Essential TB medicine with global public health relevance; mature generic market.
Generic corticosteroid with competition from newer biologics in RA; declining indication relevance.
1 discontinued, 1 duplicate formulations not shown
Based on last 4 crawl cycles
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo